Sfoglia per AUTORE
TIRONE B
Collezione AOU Novara

  

Items : 3

Efficacy and safety of JAK inhibitors in patients aged >?60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis). in Archives of dermatological research / Arch Dermatol Res. 2025 May 23;317(1):777. doi: 10.1007/s00403-025-04278-9.

2025
AOU Novara

Potestio L; Patruno C; Narcisi A; Costanzo A; Ibba L; Gargiulo L; Malagoli P; Ortoncelli M; Ribero S; Mastorino L; Leo F; Ferrucci SM; Angileri L; Barei F; Stingeni L; Hansel K; Sciarrone C; Girolomoni G; Maurelli M; Foti C; Tirone B; Balato A; Esposito M; Paolino G; Mercuri SR; Pezzolo E; Savoia P; Brescia C; Napolitano M; et alii...

Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2025 Apr 17. doi: 10.1111/jdv.20699.

2025
AOU Novara

Gargiulo L; Ferrucci SM; Ibba L; Ingurgio RC; Alfano A; Amoruso GF; Balato A; Barbagallo T; Barei F; Bellinato F; Brianti P; Burroni AG; Campanati A; Caroppo F; Carugno A; Bello GD; De Franco F; Fortina AB; Foti C; Gaiani FM; Girolomoni G; Gola M; Guanti MB; Gurioli C; Legori A; Loconsole F; Magnaterra E; Malagoli P; Margiotta FM; et alii...

Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis). in The Journal of dermatological treatment / J Dermatolog Treat. 2024 Dec;35(1):2411855. doi: 10.1080/09546634.2024.2411855. Epub 2024 Oct 10.

2024
AOU Novara

Gargiulo L; Ibba L; Alfano A; Malagoli P; Amoruso F; Balato A; Barei F; Burroni AG; Caccavale S; Calzavara-Pinton P; Esposito M; Fargnoli MC; Ferrucci SM; Foti C; Girolomoni G; Gola M; Guanti MB; Gurioli C; Magliulo M; Maurelli M; Morrone P; Musumeci ML; Napolitano M; Ortoncelli M; Patruno C; Piraccini BM; Pezzolo E; Ribero S; Rossi M; et alii...